Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a, Open Label, Dose Escalation, Safety Study of Intra-thrombus Plasmin (Human) Administration in Acute, Middle Cerebral Artery, Ischemic Stroke

NCT01014975 is registered in ClinicalTrials.gov with Grifols Therapeutics LLC as lead sponsor.

NCT NCT01014975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a, Open Label, Dose Escalation, Safety Study of Intra-thrombus Plasmin (Human) Administration in Acute, Middle Cerebral Artery, Ischemic Stroke
Lead sponsor
Grifols Therapeutics LLC
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2009
Completion date
February 28, 2014
Enrollment
40 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke